Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Venue / Journal

Nat Genet

Date

Wed, 11/01/2000 - 12:00

Additional Journal Information

26(3):291-9

Authors

Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/11062467